Betadine Solution, Ag-Gel Combo Effective for Eliminating Bacteria

WEDNESDAY, Aug. 17, 2022 (HealthDay News) -- The combination of 5 percent betadine solution and silver colloidal gel (Ag-gel) is more effective than either substance alone for inhibiting the growth of all tested bacteria, according to a study recently published in the American Journal of Infection Control.
Phat Tran, Ph.D., from the Texas Tech University Health Sciences Center in Lubbock, and colleagues examined the effectiveness of 5 percent betadine solution and Ag-gel as antimicrobial agents using a colony-forming unit assay and confocal laser scanning microscopy (CLSM).
The researchers found that with the exception of the Klebsiella pneumoniae clinical isolate strain, Ag-gel demonstrated complete inhibition of all bacteria species tested, while none of the tested bacteria were killed with 5 percent betadine concentrations. However, in the presence of both 5 percent betadine solution and Ag-gel together, K. pneumoniae was completely eliminated. Similar findings were seen with the CLSM.
"Despite substantial advancements in wound treatment and supportive care, wound infections remain a serious problem, particularly in the case of large burns," a coauthor said in a statement. "Our study is the first to systematically evaluate the use of betadine alone as compared to the combination of betadine and silver colloidal gel to eliminate bacteria and the growth of biofilms."
Abstract/Full Text (subscription or payment may be required)
Related Posts
Pediatricians’ Group Warns Against Keto Diet for Kids With Diabetes
MONDAY, Sept. 18, 2023 (HealthDay News) -- Low-carb diets may be all the rage,...
Hormonal Therapies Boost Mental Health of Transgender People, and Few Stop Treatment
TUESDAY, June 20, 2023 (HealthDay News) -- In the face of an ongoing and...
Incidence of Infections Caused by Salmonella Reduced in 2021
THURSDAY, Oct. 6, 2022 (HealthDay News) -- During 2021, there was a decrease in...
Half of Patients With Newly Diagnosed Vitiligo Do Not Receive Treatment
TUESDAY, Oct. 17, 2023 (HealthDay News) -- A high proportion of patients with...
